iVoice, Inc., (OTC Bulletin Board: IVOI), today announced that it has completed the spin-off of its wholly-owned subsidiary Thomas Pharmaceuticals Ltd. iVoice will distribute through a special dividend the Class A Common Stock shares of the subsidiary to its shareholders, and thereafter, the entity will operate as independent public company.
Each iVoice shareholder of record on November 14 2007 will receive one (1) share of Thomas Pharmaceuticals for every one (1) share of iVoice, Inc. that they own as of the record date. In order to receive shares in Thomas Pharmaceuticals, you must have owned shares of iVoice, Inc. on the record date of, November 14 2007. iVoice shareholders can expect to receive the Thomas Pharmaceuticals Ltd. shares in the next few weeks.
Thomas Pharmaceuticals Ltd. will file the appropriate paperwork with the NASD to begin trading on the NASD Over the Counter Bulletin Board. The companies expect that the shares will commence trading sometime in the next several months.
Registration statements relating to the securities of Thomas Pharmaceuticals Ltd. have been filed with and declared effective by the Securities and Exchange Commission. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor there any sale of these securities in any state in which such offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the Company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com
